Cargando…
P02-027 - Quality of life in CAPS treated by Canakinumab
Autores principales: | Marsaud, C, Marie, I, Koné-Paut, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952177/ http://dx.doi.org/10.1186/1546-0096-11-S1-A134 |
Ejemplares similares
-
PW02-041 - Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013) -
PW02-027 - CAPS and cost-effectiveness analysis project
por: Alberighi, O Della Casa, et al.
Publicado: (2013) -
P02-026 - Model-based characterization of the PKPD relationship for canakinumab in CAPS: a step towards personalized
por: Gautier, A, et al.
Publicado: (2013) -
P02-008 - Dramatic response to canakinumab in MKD
por: Makay, B, et al.
Publicado: (2013) -
P02-009 - Candle syndrome: expanding spectrum
por: Kone-Paut, I, et al.
Publicado: (2013)